vs

Side-by-side financial comparison of Black Rock Coffee Bar, Inc. (BRCB) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

Black Rock Coffee Bar, Inc. is the larger business by last-quarter revenue ($51.5M vs $44.6M, roughly 1.2× PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). Black Rock Coffee Bar, Inc. runs the higher net margin — -1.4% vs -90.4%, a 89.0% gap on every dollar of revenue. PACIFIC BIOSCIENCES OF CALIFORNIA, INC. produced more free cash flow last quarter ($-19.9M vs $-25.8M).

Black Rock Coffee Bar, Inc. is a U.S.-based specialty coffee retail chain that offers handcrafted premium coffee beverages, energy drinks, baked goods, and light snacks. It operates in-store and drive-thru locations primarily across western U.S. states, prioritizing high-quality customizable products and community-focused consumer experiences.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

BRCB vs PACB — Head-to-Head

Bigger by revenue
BRCB
BRCB
1.2× larger
BRCB
$51.5M
$44.6M
PACB
Higher net margin
BRCB
BRCB
89.0% more per $
BRCB
-1.4%
-90.4%
PACB
More free cash flow
PACB
PACB
$5.9M more FCF
PACB
$-19.9M
$-25.8M
BRCB

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BRCB
BRCB
PACB
PACB
Revenue
$51.5M
$44.6M
Net Profit
$-712.0K
$-40.4M
Gross Margin
37.1%
Operating Margin
-12.4%
-92.3%
Net Margin
-1.4%
-90.4%
Revenue YoY
13.8%
Net Profit YoY
-1802.7%
EPS (diluted)
$-0.05
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BRCB
BRCB
PACB
PACB
Q4 25
$44.6M
Q3 25
$51.5M
$38.4M
Q2 25
$39.8M
Q1 25
$37.2M
Q4 24
$39.2M
Q3 24
$40.0M
Q2 24
$36.0M
Q1 24
$38.8M
Net Profit
BRCB
BRCB
PACB
PACB
Q4 25
$-40.4M
Q3 25
$-712.0K
$-38.0M
Q2 25
$-41.9M
Q1 25
$-426.1M
Q4 24
$2.4M
Q3 24
$-60.7M
Q2 24
$-173.3M
Q1 24
$-78.2M
Gross Margin
BRCB
BRCB
PACB
PACB
Q4 25
37.1%
Q3 25
41.4%
Q2 25
36.9%
Q1 25
-3.7%
Q4 24
25.6%
Q3 24
25.0%
Q2 24
16.5%
Q1 24
29.1%
Operating Margin
BRCB
BRCB
PACB
PACB
Q4 25
-92.3%
Q3 25
-12.4%
-101.1%
Q2 25
-112.8%
Q1 25
-1154.5%
Q4 24
-390.1%
Q3 24
-160.3%
Q2 24
-488.3%
Q1 24
-209.6%
Net Margin
BRCB
BRCB
PACB
PACB
Q4 25
-90.4%
Q3 25
-1.4%
-98.9%
Q2 25
-105.4%
Q1 25
-1146.8%
Q4 24
6.0%
Q3 24
-151.9%
Q2 24
-481.3%
Q1 24
-201.4%
EPS (diluted)
BRCB
BRCB
PACB
PACB
Q4 25
$-0.11
Q3 25
$-0.05
$-0.13
Q2 25
$-0.14
Q1 25
$-1.44
Q4 24
$-0.44
Q3 24
$-0.22
Q2 24
$-0.64
Q1 24
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BRCB
BRCB
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$32.6M
$279.5M
Total DebtLower is stronger
$20.0M
Stockholders' EquityBook value
$43.0M
$5.3M
Total Assets
$323.2M
$784.1M
Debt / EquityLower = less leverage
0.46×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BRCB
BRCB
PACB
PACB
Q4 25
$279.5M
Q3 25
$32.6M
$298.7M
Q2 25
$314.7M
Q1 25
$343.1M
Q4 24
$389.9M
Q3 24
$471.1M
Q2 24
$509.8M
Q1 24
$561.9M
Total Debt
BRCB
BRCB
PACB
PACB
Q4 25
Q3 25
$20.0M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BRCB
BRCB
PACB
PACB
Q4 25
$5.3M
Q3 25
$43.0M
$36.1M
Q2 25
$61.5M
Q1 25
$91.6M
Q4 24
$506.6M
Q3 24
$453.1M
Q2 24
$492.7M
Q1 24
$649.0M
Total Assets
BRCB
BRCB
PACB
PACB
Q4 25
$784.1M
Q3 25
$323.2M
$803.2M
Q2 25
$825.5M
Q1 25
$860.8M
Q4 24
$1.3B
Q3 24
$1.5B
Q2 24
$1.5B
Q1 24
$1.7B
Debt / Equity
BRCB
BRCB
PACB
PACB
Q4 25
Q3 25
0.46×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BRCB
BRCB
PACB
PACB
Operating Cash FlowLast quarter
$-2.9M
$-19.1M
Free Cash FlowOCF − Capex
$-25.8M
$-19.9M
FCF MarginFCF / Revenue
-50.2%
-44.6%
Capex IntensityCapex / Revenue
44.5%
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BRCB
BRCB
PACB
PACB
Q4 25
$-19.1M
Q3 25
$-2.9M
$-18.7M
Q2 25
$-29.4M
Q1 25
$-44.1M
Q4 24
$-30.6M
Q3 24
$-45.5M
Q2 24
$-54.3M
Q1 24
$-75.7M
Free Cash Flow
BRCB
BRCB
PACB
PACB
Q4 25
$-19.9M
Q3 25
$-25.8M
$-18.8M
Q2 25
$-29.9M
Q1 25
$-45.4M
Q4 24
$-32.3M
Q3 24
$-46.3M
Q2 24
$-55.7M
Q1 24
$-79.6M
FCF Margin
BRCB
BRCB
PACB
PACB
Q4 25
-44.6%
Q3 25
-50.2%
-48.9%
Q2 25
-75.3%
Q1 25
-122.3%
Q4 24
-82.3%
Q3 24
-115.7%
Q2 24
-154.8%
Q1 24
-205.0%
Capex Intensity
BRCB
BRCB
PACB
PACB
Q4 25
1.9%
Q3 25
44.5%
0.2%
Q2 25
1.4%
Q1 25
3.7%
Q4 24
4.1%
Q3 24
2.0%
Q2 24
4.1%
Q1 24
10.0%
Cash Conversion
BRCB
BRCB
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-12.93×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BRCB
BRCB

Segment breakdown not available.

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons